Stock Overview

Guardant Health Inc (GH)

NASDAQ · Healthcare · Diagnostics & Research

Guardant Health Inc is a Healthcare company with a market capitalization of $21.57B.

Market Cap
$21.57B
Price/Sales
18.2
Price/Book
53.1
EV/EBITDA
-5.2
Beta
1.59
EPS (TTM)
$-3.51
Profit Margin
-40.1%
ROE
-4584.0%
Short % of Float
8.8%
Days to Cover
4.1
52W High
$170.77
52W Low
$54.79

5-Year Price History

Latest Annual Financials · FY ending December 31, 2025

Revenue
$982.02M
Gross Profit
$633.01M
Operating Income
-$436.30M
Net Income
-$416.28M
Free Cash Flow
-$233.07M
Total Debt
$1.53B
Cash & Equivalents
$378.20M
Shareholder Equity
-$99.31M

Recent Quarterly Earnings (EPS)

QuarterReportedActual EPSEstimateSurprise
Q1 2026May 7, 2026$-0.45$-0.47+4.3%
Q4 2025February 19, 2026$-0.50$-0.47-6.4%
Q3 2025October 29, 2025$-0.39$-0.49+20.4%
Q2 2025July 30, 2025$-0.44$-0.51+13.7%
Q1 2025April 30, 2025$-0.49$-0.59+17.0%
Q4 2024February 20, 2025$-0.62$-0.50-23.1%

Short Interest

FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.

SettlementShares Short% of Shares OutDays to CoverChange
July 15, 202611,421,0158.70%4.1-5.9%
June 30, 202612,141,1659.25%2.9-7.2%
June 15, 202613,087,2559.97%6.4-0.9%
May 29, 202613,207,29810.06%4.5+2.1%
May 15, 202612,930,3419.85%7.1+1.0%
April 30, 202612,806,4149.95%6.1+10.0%
April 15, 202611,642,1099.05%5.1-15.0%
March 31, 202613,696,67610.65%7.5+19.6%

Other Diagnostics & Research Stocks

Frequently Asked Questions

What is Guardant Health Inc's market cap?

As of August 13, 2026, Guardant Health Inc (GH) has a market capitalization of $21.57B.

Does Guardant Health Inc pay a dividend?

Guardant Health Inc does not currently pay a dividend.

What sector is GH in?

Guardant Health Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.

What is Guardant Health Inc's short interest?

As of the July 15, 2026 FINRA settlement, 11,421,015 GH shares were sold short, or 8.70% of shares outstanding. Days to cover: 4.1. FINRA publishes short interest twice a month, about nine business days after each settlement date.

What was Guardant Health Inc's revenue?

In its latest reported fiscal year (ending December 31, 2025), Guardant Health Inc reported revenue of $982.02M and net income of -$416.28M.

Ask your own questions about GH

Try mrmarket.ai free

Data as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.